Why Intensity Determines Gait Outcomes Post-Stroke
After a stroke, gait often recovers 'sufficiently' for household mobility but not for real-world community participation: walking endurance is deficient, early fatigue emerges, and performance deteriorates under dual-task demands or complex environments. The ESO 2025 guideline formally establishes what clinicians observe daily: meaningful gait improvement requires adequate dosing (step volume) and intensity (cardiovascular load), delivered safely. This article provides an operational guide: selection criteria, contraindications, monitoring protocols, stop rules, and a base protocol for implementing HIGT (High-Intensity Gait Training).
ESO 2025 Recommendations on High-Intensity Gait Training
The European Stroke Organisation (ESO) guideline (2025) establishes two actionable principles:
- Minimum additional dose (expert consensus): Approximately 20 extra hours of walking practice may be beneficial for walking capacity. This translates to programming a block of 4–6 weeks with 3–5 sessions/week.
- High intensity (moderate certainty evidence): Strong recommendation for high-intensity gait training to improve walking endurance in individuals with chronic stroke and stable cardiovascular health. Weak recommendation for improving walking speed.
Expected Benefits (and What NOT to Promise)
- Walking endurance: Primary outcome with strong recommendation in stable chronic stroke. This is the benefit with the strongest evidence base.
- Gait function: Improvements observed when training emphasises stepping practice at elevated cardiovascular intensity.
- Walking speed: The ESO 2025 assigns a weak recommendation (low certainty evidence). Possible but more variable.
Clinicians should not guarantee complete gait recovery across all patient profiles, meaningful gains without adequate step dosing, or sustained improvements without a maintenance programme.
Clinical Selection Criteria: Who Is a Candidate for HIGT?
- Typical candidate (ideal profile): Chronic stroke, with ambulatory capacity (even if assisted) and a clear goal to improve endurance. Stable cardiovascular status (no signs of clinical instability). Ability to tolerate interval training (even if initially brief).
- Potential candidate (subacute phase): Evidence supports moderate-to-high intensity exercise in the subacute phase with appropriate selection, medical collaboration and active monitoring of serious adverse events. Requires stricter screening.
Safety: Screening, Monitoring and Stop Rules
Minimum Screening (Before Intensity Escalation)
- Directed clinical history: chest pain, disproportionate dyspnoea, syncope/pre-syncope, palpitations, recent decompensation episodes.
- Baseline vital signs: blood pressure (BP), heart rate (HR), SpO₂ where appropriate.
- Medication review: beta-blockers (alter target HR), antihypertensives, antiarrhythmics.
- Functional neurological risk: falls, hemispatial neglect, attentional deficits (for treadmill or overground environments).
Intra-Session Monitoring
- HR (ideally via chest strap or reliable pulse oximeter).
- BP (pre, mid-session if elevated risk, post).
- RPE (Borg Rating of Perceived Exertion) 0–10 or 6–20 scale.
- Symptom surveillance: chest pain, unusual dyspnoea, dizziness, severe headache, visual disturbance, sudden weakness.
Stop Rules (Clinical Practice Version)
- Chest pain or angina, pre-syncope, severe dizziness.
- Disproportionate dyspnoea or signs of poor perfusion.
- BP with abnormal surge or drop.
- Symptomatic arrhythmia or HR inconsistent with exertion level.
- Acute neurological signs (new deficit, sudden confusion).
Defining 'High Intensity' in Post-Stroke Rehabilitation
In practice, exercise intensity can be prescribed via: % heart rate reserve (HRR) or % HRmax (when reliable measurement is available); RPE (highly practical in clinical settings, particularly with medications altering HR response); and speed/incline + steps/minute as a functional proxy. In interval training paradigms, ranges of 70–90% HRmax or 60–85% HRR during work intervals are described, though prescription must be individualised to the post-stroke profile and concurrent pharmacotherapy.
Clinical quick-start rule: Week 1 with intervals at RPE 7–8/10 with adequate rest periods. Progression by increasing time in target zone and/or total step count while maintaining safe technique.
HIGT Protocol (4–6 Weeks) Aligned with ESO 2025
Objective: deliver adequate dosing (step volume) + high cardiovascular intensity with measurable fidelity.
3–5 days/week (per tolerance and logistics). 30–45 net minutes of training (excluding preparation). Programme to accumulate ≥20 additional hours of walking practice over 4–6 weeks.
Body-weight supported treadmill (BWS) enables higher step counts with reduced fall risk. IMUs and step counters quantify 'real dose'. A fidelity dashboard records steps per session + percentage of time in target intensity zone.
Clinical Decision Table
Evidence Sources
Fuentes
- European Stroke Organisation (ESO): Motor Rehabilitation Guideline 2025 — strong recommendation for HIGT in chronic stroke
- HIGT implementation studies with fidelity metrics (step counts + achieved HR zones)
- Systematic reviews on moderate-to-high intensity exercise in subacute stroke with cardiovascular safety
- Evidence on interval training (HIIT) adapted for post-stroke rehabilitation
Request a functional assessment + tolerance testing + 4–6 week high-intensity gait training programme with metrics and fidelity dashboard at GNeuro.